NO20053010L - Flytende farmasoytiske preparater inneholdende 3,7- diazabisyklo [3,3,1] nonaner for behandling av anti- arytmiske hendelser. - Google Patents
Flytende farmasoytiske preparater inneholdende 3,7- diazabisyklo [3,3,1] nonaner for behandling av anti- arytmiske hendelser.Info
- Publication number
- NO20053010L NO20053010L NO20053010A NO20053010A NO20053010L NO 20053010 L NO20053010 L NO 20053010L NO 20053010 A NO20053010 A NO 20053010A NO 20053010 A NO20053010 A NO 20053010A NO 20053010 L NO20053010 L NO 20053010L
- Authority
- NO
- Norway
- Prior art keywords
- antiarrhythmic
- diazabicyclo
- events
- treatment
- liquid pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4747—Quinolines; Isoquinolines spiro-condensed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicinal Preparation (AREA)
Abstract
Den foreliggende oppfinnelse vedrører anvendelsen av 3,7-diazabisyklo[3,3,1]nonanforbindelser, fortrinnsvis av 9,9-alkylen-3,7diazabisyklo[3,3,1]nonan-forbindelser, og mest foretrukket anvendelsen av tedisamil, og de fysiologisk akseptable syreaddisjonssaltene og/eller solvatene derav, i form av et flytende farmasøytisk preparat for behandling og/eller profylakse av anti-arytmiske hendelser hos menneskepasienter, fortrinnsvis ved omstilling av nylig oppstart av atrieflimmer (Afib) eller hjertebank til normal sinusrytme (NSR) hos menneskepasienter. Dessuten vedrører oppfinnelsen en fremgangsmåte for behandlinger, og farmasøytiske produkter.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US42679502P | 2002-11-18 | 2002-11-18 | |
PCT/EP2003/012844 WO2004045591A2 (en) | 2002-11-18 | 2003-11-17 | Liquid pharmaceutical formulations containing 3,7-diazabicyclo`3,3,1! nonanes for treating anti-arrhythmic events |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20053010L true NO20053010L (no) | 2005-06-20 |
Family
ID=32326429
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20053010A NO20053010L (no) | 2002-11-18 | 2005-06-20 | Flytende farmasoytiske preparater inneholdende 3,7- diazabisyklo [3,3,1] nonaner for behandling av anti- arytmiske hendelser. |
Country Status (20)
Country | Link |
---|---|
US (2) | US7087620B2 (no) |
EP (1) | EP1565239B8 (no) |
JP (1) | JP2006510613A (no) |
KR (1) | KR101059330B1 (no) |
CN (1) | CN1726062A (no) |
AR (1) | AR042199A1 (no) |
AT (1) | ATE501758T1 (no) |
AU (1) | AU2003296580B8 (no) |
BR (1) | BR0316383A (no) |
CA (1) | CA2506083A1 (no) |
DE (1) | DE60336417D1 (no) |
IL (1) | IL168630A (no) |
MX (1) | MXPA05005344A (no) |
NO (1) | NO20053010L (no) |
RU (1) | RU2358732C2 (no) |
SA (1) | SA04250023B1 (no) |
TW (1) | TW200418468A (no) |
UA (1) | UA85546C2 (no) |
WO (1) | WO2004045591A2 (no) |
ZA (1) | ZA200504049B (no) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW200418468A (en) * | 2002-11-18 | 2004-10-01 | Solvay Pharm Gmbh | Liquid pharmaceutical formulations containing 3,7-diazabicyclo[3,3,1]nonane compounds and method of treatments relating to anti-arrhytmic events |
US20050054667A1 (en) * | 2003-07-21 | 2005-03-10 | Solvay Pharmaceuticals Gmbh | Method of treating or inhibiting anti-arrhythmic events in male human patients |
MXPA06000796A (es) * | 2003-07-21 | 2006-04-07 | Solvay Pharm Gmbh | Uso de los compuestos 3,7-diazabiciclo [3,3,1]nonano para el tratamiento y/o profilaxis de eventos antiarritmicos en pacientes humanos varones. |
EP1917979A4 (en) * | 2005-08-23 | 2009-06-03 | Astellas Pharma Inc | THERAPEUTICS FOR PREVIOUS LIVING ROOMS |
EP2149370A1 (en) * | 2008-07-31 | 2010-02-03 | Neuroscienze Pharmaness S.C. A R.L. | Diazabicyclic compounds and microemulsions thereof |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4550111A (en) * | 1982-01-29 | 1985-10-29 | Imperial Chemical Industries Plc | Alkanolamine derivatives |
DE3234697A1 (de) | 1982-09-18 | 1984-03-22 | Kali-Chemie Pharma Gmbh, 3000 Hannover | Neue diazabicyclo-(3,3,1)-nonane |
PT88381B (pt) * | 1987-09-09 | 1995-07-06 | Kali Chemie Pharma Gmbh | Processo para a preparacao de novos compostos 3,7-diazabiciclo{3,3,1} nonano, e de composicoes farmaceuticas que contem estes compostos |
DE4019080A1 (de) * | 1990-06-15 | 1991-12-19 | Kali Chemie Pharma Gmbh | Neue 3,7-diazabicycolo (3,3,1)nonan-verbindungen enthaltende arzneimittel |
DE4139763A1 (de) * | 1991-12-03 | 1993-06-09 | Kali-Chemie Pharma Gmbh, 3000 Hannover, De | Kristalline fumarsaure salze von 9,9-alkylen-3,7-diazabicyclononan-verbindungen und diese verbindungen enthaltende arzneimittel |
DE4402931A1 (de) * | 1994-02-01 | 1995-08-03 | Kali Chemie Pharma Gmbh | Neue 3-Phenylsulfonyl-3,7-diazabicyclo[3,3,1] nonan-Verbindungen enthaltende Arzneimittel |
DE4402933A1 (de) * | 1994-02-01 | 1995-08-03 | Kali Chemie Pharma Gmbh | Neue 3-Benzoyl-3,7-diazabicyclo[3,3,1] nonan-Verbindungen enthaltende Arzneimittel |
US5576349A (en) * | 1995-11-30 | 1996-11-19 | The General Hospital Corporation | Retionoic acid treatment of cardiac arrhythmia |
US6026817A (en) * | 1996-11-14 | 2000-02-22 | Clemens; Anton H. | Method of treating the syndrome of coronary heart disease risk factors in humans |
SE9704709D0 (sv) * | 1997-12-17 | 1997-12-17 | Astra Ab | Pharmaceutically active compounds |
US6790463B2 (en) * | 2001-03-30 | 2004-09-14 | Robert F. Hofmann | Uses of targeted oxidative therapeutic formulation in arteriosclerosis |
DE10131217A1 (de) * | 2001-06-28 | 2003-01-09 | Solvay Pharm Gmbh | 3-Phenyl-3,7-diazabicyclo 3,3,1 nonan-Verbindungen sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
TW200418468A (en) * | 2002-11-18 | 2004-10-01 | Solvay Pharm Gmbh | Liquid pharmaceutical formulations containing 3,7-diazabicyclo[3,3,1]nonane compounds and method of treatments relating to anti-arrhytmic events |
-
2003
- 2003-11-13 TW TW092131744A patent/TW200418468A/zh unknown
- 2003-11-17 CN CNA2003801061229A patent/CN1726062A/zh active Pending
- 2003-11-17 WO PCT/EP2003/012844 patent/WO2004045591A2/en active Application Filing
- 2003-11-17 CA CA002506083A patent/CA2506083A1/en not_active Abandoned
- 2003-11-17 RU RU2005119280/15A patent/RU2358732C2/ru not_active IP Right Cessation
- 2003-11-17 EP EP03811379A patent/EP1565239B8/en not_active Expired - Lifetime
- 2003-11-17 MX MXPA05005344A patent/MXPA05005344A/es unknown
- 2003-11-17 UA UAA200505967A patent/UA85546C2/ru unknown
- 2003-11-17 JP JP2004552627A patent/JP2006510613A/ja not_active Ceased
- 2003-11-17 AT AT03811379T patent/ATE501758T1/de not_active IP Right Cessation
- 2003-11-17 DE DE60336417T patent/DE60336417D1/de not_active Expired - Lifetime
- 2003-11-17 BR BR0316383-0A patent/BR0316383A/pt not_active IP Right Cessation
- 2003-11-17 AR ARP030104235A patent/AR042199A1/es not_active Application Discontinuation
- 2003-11-17 AU AU2003296580A patent/AU2003296580B8/en not_active Ceased
- 2003-11-17 KR KR1020057008973A patent/KR101059330B1/ko not_active IP Right Cessation
- 2003-11-18 US US10/715,130 patent/US7087620B2/en not_active Expired - Fee Related
-
2004
- 2004-03-03 SA SA04250023A patent/SA04250023B1/ar unknown
-
2005
- 2005-05-17 IL IL168630A patent/IL168630A/en not_active IP Right Cessation
- 2005-05-19 ZA ZA200504049A patent/ZA200504049B/en unknown
- 2005-06-20 NO NO20053010A patent/NO20053010L/no not_active Application Discontinuation
- 2005-07-13 US US11/179,635 patent/US20050261300A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
BR0316383A (pt) | 2005-10-04 |
EP1565239B1 (en) | 2011-03-16 |
TW200418468A (en) | 2004-10-01 |
ZA200504049B (en) | 2006-07-26 |
AU2003296580B8 (en) | 2010-03-18 |
CA2506083A1 (en) | 2004-06-03 |
US20040152716A1 (en) | 2004-08-05 |
ATE501758T1 (de) | 2011-04-15 |
SA04250023B1 (ar) | 2008-12-23 |
AU2003296580A1 (en) | 2004-06-15 |
AU2003296580B2 (en) | 2010-02-18 |
EP1565239A2 (en) | 2005-08-24 |
WO2004045591A3 (en) | 2004-07-22 |
UA85546C2 (en) | 2009-02-10 |
IL168630A (en) | 2013-08-29 |
CN1726062A (zh) | 2006-01-25 |
RU2005119280A (ru) | 2006-03-20 |
JP2006510613A (ja) | 2006-03-30 |
RU2358732C2 (ru) | 2009-06-20 |
EP1565239B8 (en) | 2011-06-22 |
KR20050116125A (ko) | 2005-12-09 |
AR042199A1 (es) | 2005-06-15 |
US20050261300A1 (en) | 2005-11-24 |
US7087620B2 (en) | 2006-08-08 |
WO2004045591A2 (en) | 2004-06-03 |
KR101059330B1 (ko) | 2011-08-24 |
DE60336417D1 (de) | 2011-04-28 |
MXPA05005344A (es) | 2005-08-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Hegemann et al. | Direct interaction of antifungal azole-derivatives with calmodulin: a possible mechanism for their therapeutic activity | |
NO20053010L (no) | Flytende farmasoytiske preparater inneholdende 3,7- diazabisyklo [3,3,1] nonaner for behandling av anti- arytmiske hendelser. | |
CN102056603A (zh) | 决奈达隆用于预防持续性心房纤颤 | |
Parker et al. | Nitroglycerin lingual spray: clinical efficacy and dose-response relation | |
KR0128057B1 (ko) | 피부 미소순환에 작용하는 약리적 조성물 | |
Lederballe Pedersen | Comparison of metoprolol and hydrochlorothiazide as antihypertensive agents | |
Page et al. | Antiarrhythmic effects of azimilide in paroxysmal supraventricular tachycardia: efficacy and dose-response | |
Ekbom et al. | The stroke preventive effect in elderly hypertensives cannot fully be explained by the reduction in office blood pressure–insights from the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension) | |
Tio et al. | Evidence for differential sympathetic and parasympathetic reinnervation after heart transplantation in humans | |
ES2207486T3 (es) | Preparacion para verrugas. | |
MXPA06000796A (es) | Uso de los compuestos 3,7-diazabiciclo [3,3,1]nonano para el tratamiento y/o profilaxis de eventos antiarritmicos en pacientes humanos varones. | |
Lacourciere | Analysis of well-being and 24-hour blood pressure recording in a comparative study between indapamide and captopril | |
Hill et al. | Effect of bepridil in patients with chronic stable angina: results of a multicenter trial. | |
SU1607808A1 (ru) | Способ лечени кардиоплечегрудного синдрома у больных с инфарктом миокарда в фазе реконвалесценции | |
Leonetti et al. | Effects of nilvadipine and amlodipine in patients with mild to moderate essential hypertension: a double blind, prospective, randomised clinical trial | |
Hubner et al. | Assessment of dermal glyceryl trinitrate and isosorbide dinitrate for patients with angina pectoris. | |
Banai et al. | Effect of nisoldipine on myocardial ischemia: evaluation by Holter monitoring | |
TH84974A (th) | สูตรผสมเภสัชภัณฑ์ชนิดของเหลวซึ่งมีสารประกอบ 3,7-ไดอะซาไบไซโคล [3,3,1] โนเนนและวิธีการของการทรีตเมนท์ซึ่งเกี่ยวข้องกับปรากฏการณ์ภาวะหัวใจเต้นผิดจังหวะ | |
NO952426L (no) | Nytt legemiddel som inneholder 3,7-diazabisyklo[3,3,1Ånonan forbindelser | |
Sowton et al. | Clinical assessment of “Etrynit” for angina pectoris | |
Chambers et al. | Familial sudden death syndrome with an abnormal signal-averaged electrocardiogram as a potential marker | |
Poncelet et al. | A double-blind, randomized, comparative study of nitrendipine and enalapril in elderly hypertensive patients | |
Prandota et al. | Long QT syndrome precipitated by atropine and hypokalemia | |
Shugushev et al. | Electrophysiologic effects of ethmozin on sinus node function in patients with and without sinus node dysfunction | |
Fauzy et al. | Research Article Piper sarmentosum Leaves Aqueous Extract Attenuates Vascular Endothelial Dysfunction in Spontaneously Hypertensive Rats |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |